Looking for a new type of health insurance?
by Lisa Fritzky, on Jan 9, 2019 3:40:44 PM
Open enrollment for health insurance may now be closed, but we're still open at Silene Biotech.
Many people ask us why they should preserve their cells now if they don’t know if they’ll need them in the future. A couple of reasons to consider it:
1. How confident would you feel if you didn’t have car insurance? A healthcare plan? Insurance for your home? We like to describe our stem cell preservation service, StemFreeze, as an insurance policy for your future health. Similar to your current health insurance plan, you’ll never know if you will need to be insured, but you continue to pay those monthly fees to ensure that you’re covered just in case (knock on wood) something should happen to you.
2. Time is of the essence with this type of insurance plan. As you age, your stem cells age along with you and develop DNA mutations caused by damage from our environment and daily life, like stress or lifestyle choices. However, most cells in the body have limited self-renewal capabilities, and over time, your body loses its ability to maintain healthy organs and prevent degenerative diseases due to decreased reserves of healthy cells. By preserving your cells today, you are storing the youngest and healthiest stem cells you will ever have, which makes them more potent and vibrant for future use if/when you ever need them. You can download our free cellular aging guide to learn more.
Don’t just take our word for it. Meet our customer, Sarah, who knows firsthand the importance of investing in health:
I was born with a heart condition and survived an experimental surgery, it healed well, then I found out about another heart condition at the age of 16. This second one is a bicuspid valve - something that 1.3% of the population also has. As a woman in tech with a career in 3D Printing, I know that we are on the cusp of significant innovation in medical procedures through the combinations of these technologies. It couldn't be more clear that now is the time to invest in my future. The blood draw was quick, the team was flexible with work schedules, and accompanied me through the process. Thank you, Silene!"
And to Sarah's point, this year marks a significant milestone in the field of heart disease: the first clinical trial using reprogrammed (iPS) stem cells will be used on patients who have heart damage. The clinical trial will implant sheets containing 100-million stem cells turned into heart cells to regenerate damaged heart tissue. The trial is set to kick off in Japan early this year and will be led by a cardiac surgeon from Osaka University. You can read more about this study here.